BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12785236)

  • 21. Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias.
    Vissenberg I; Dieleman-Smet H; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1993; 248():77-82. PubMed ID: 8044337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
    Wang J; Lin S; Zhang X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of botulinum toxin in dentistry.
    Hoque A; McAndrew M
    N Y State Dent J; 2009 Nov; 75(6):52-5. PubMed ID: 20069790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of focal dystonia with botulinum toxin].
    Gjerstad L; Kerty E; Nyberg-Hansen R
    Tidsskr Nor Laegeforen; 1991 Sep; 111(21):2637-9. PubMed ID: 1948848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
    Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
    Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin therapy.
    Savino PJ; Maus M
    Neurol Clin; 1991 Feb; 9(1):205-24. PubMed ID: 2011110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facial dystonia, essential blepharospasm and hemifacial spasm.
    Holds JB; White GL; Thiese SM; Anderson RL
    Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of facial muscle squeezing versus non-facial muscle squeezing on the efficacy of botulinumtoxin-A injections for the treatment of facial dystonia.
    O' Reilly P; Ross J; Norris J; Malhotra R
    Orbit; 2012 Dec; 31(6):400-3. PubMed ID: 23061606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
    Ziak P
    Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A; Brannan PA
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hyperfunctional facial lines with botulinum toxin].
    Böni R; Kargl A; Kreyden OP; Burg G
    Praxis (Bern 1994); 2001 Aug; 90(34):1408-12. PubMed ID: 11552321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications.
    Borodic G
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):11-6, v. PubMed ID: 17317551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botox. It's not just for wrinkles.
    Mayo Clin Womens Healthsource; 2003 Nov; 7(11):1-2. PubMed ID: 14608225
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology.
    Ophthalmology; 1989 Sep; Suppl():37-41. PubMed ID: 2779991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.